Ewing Sarcoma Breakpoint Region 1 (EWSR1) (Middle Region) Peptid
EWSR1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle EWSR1 Produkte
- EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-EWSR1 antibody (Catalog #: ARP38594_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
- Synonyme
- EWS Peptide, bK984G1.4 Peptide, AU018891 Peptide, Ews Peptide, Ewsh Peptide, EWSR1 Peptide, fc04c01 Peptide, wu:fc04c01 Peptide, DKFZp459K1116 Peptide, ewsr1 Peptide, ewsr1.S Peptide, fb40b11 Peptide, fusl Peptide, wu:fb40b11 Peptide, wu:fb75g09 Peptide, zgc:55864 Peptide, EWS RNA binding protein 1 Peptide, Ewing sarcoma breakpoint region 1 Peptide, EWS RNA-binding protein 1 Peptide, EWS RNA-binding protein 1a Peptide, EWS RNA binding protein 1 L homeolog Peptide, EWS RNA-binding protein 1b Peptide, EWSR1 Peptide, Ewsr1 Peptide, ewsr1a Peptide, ewsr1 Peptide, ewsr1.L Peptide, ewsr1b Peptide
- Hintergrund
-
EWSR1 is a putative RNA binding protein. Mutations in this gene, specifically a t(11,22)(q24,q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in two products.This gene encodes a putative RNA binding protein. Mutations in this gene, specifically a t(11,22)(q24,q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in two products.
Alias Symbols: EWS, bK984G1.4
Protein Interaction Partner: ACTL6A,AGT,ATN1,ATXN3,BAD,BARD1,BNIP3L,BTK,C10orf12,C11orf16,C18orf10,C19orf50,C19orf57,CALM1,CCDC7,CCDC91,CD177,CEACAM5,CETP,CFDP1,CNST,CPSF6,CPSF7,CREBBP,CUEDC2,CXADR,DFFA,DMRTB1,DNAJB3,DYNLL2,ELAVL3,ELAVL4,EPT1,ERCC5,EWSR1,FAM131C,FASN,FLI1,GNPDA1,GPBP1L1,HBP1,HERPUD1,HMGA1,HSPA2,KCNMB1,KEL,KHDRBS2,KRR1,LILRA3,MAGEA11,MAPK1IP1L,MATK,MDFI,MNS1,MRPS18B,MSC,MTCP1,MTMR9,MVK,MYL6,MYO1F,MYOZ2,NBPF3,NDRG1,NDUFB1,NDUFV1,NINL,NLE1,NPPB,NSUN4,NTNG2,PCBP1,PDHX,PGLS,PLSCR1,POLR2G,POU4F1,POU5F1,PRKCA,PRTFDC1,PRUNE2,PTK2B,RAB37,RAD23A,RALYL,RASL11B,RBPMS,RHOXF2,RMND5B,RNF183,RPL31,RPS15A,SALL2,SERP2,SF1,SLC1A1,SMAD1,SMAD4,SNRPC,SSBP2,SUV39H2,TAF1,TMSB4Y,TRIM37,TRPV5,TSPAN3,TULP2,USP7,VPS72,WDR37,WWP1,WWP2,YWHAG,YY1AP1,ZDHHC3,ZNF165,ACTL6A,AGT,ARHGDIA,BAD,BARD1,BNIP3L,BTK,C10orf12,C11orf16,C18orf10,C19orf50,C19orf57,CALM1,CCDC7,CCDC91,CD177,CD2BP2,CEACAM5,CETP,CFDP1,CNST,CPSF6,CPSF7,CREBBP,CUEDC2,CXADR,DFFA,DMRTB1,DNAJB3,DYNLL2,ELAVL3,ELAVL4,ELK1,EPT1,FAM131C,FASN,GNPDA1,GPBP1L1,GSK3B,HERPUD1,HMGA1,ILK,KCNMB1,KEL,KHDRBS2,KRR1,LILRA3,MAGEA11,MAPK1IP1L,MATK,MDFI,MNS1,MRPS18B,MSC,MTCP1,MTMR9,MVK,MYL6,MYO1F,MYOZ2,NBPF3,NDUFB1,NDUFV1,NINL,NLE1,NPPB,NSUN4,NTNG2,PDHX,PGLS,PLSCR1,POU4F1,PRTFDC1,PRUNE2,PTK2B,PUF60,RAB37,RAD23A,RALYL,RASL11B,RBPMS,RHOXF2,RMND5B,RNF183,RPL31,RPS15A,SALL2,SERP2,SF1,SLC1A1,SLC22A24,SMAD4,SMNDC1,SNRPC,SSBP2,SUV39H2,TMSB4Y,TRIM37,TRPV5,TSPAN3,TULP2,VPS72,WDR37,WWP1,WWP2,YY1AP1,ZDHHC3,ZNF165
Protein Size: 656 - Molekulargewicht
- 68 kDa
- Gen-ID
- 2130
- NCBI Accession
- NM_005243, NP_005234
- UniProt
- Q01844
-
Sie sind hier:
